* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Solutions to Genetics Day 6 Interpretation Questions
Nutriepigenomics wikipedia , lookup
Comparative genomic hybridization wikipedia , lookup
Human genome wikipedia , lookup
SNP genotyping wikipedia , lookup
DNA profiling wikipedia , lookup
Genome evolution wikipedia , lookup
Mitochondrial DNA wikipedia , lookup
Zinc finger nuclease wikipedia , lookup
DNA polymerase wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Designer baby wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Genetic engineering wikipedia , lookup
Primary transcript wikipedia , lookup
Transposable element wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Genealogical DNA test wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Point mutation wikipedia , lookup
Microsatellite wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
DNA vaccination wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Epigenomics wikipedia , lookup
Nucleic acid double helix wikipedia , lookup
Molecular cloning wikipedia , lookup
Non-coding DNA wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Microevolution wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
DNA supercoil wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Genome editing wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Genomic library wikipedia , lookup
Helitron (biology) wikipedia , lookup
History of genetic engineering wikipedia , lookup
Solutions to Genetics Day 6 Interpretation Questions 1. Interpret your data from Genetics Day 5. Some issues to consider… • • • • Are the Ara- and KanR phenotypes linked in your mutant strains? Are the phenotypes consistent among the four transductants from the same mutant strain? Did your LacZ phenotype remain consistent before and after transduction? Are there any unusual observations? Assuming that the KanR and Ara- phenotypes are linked, you should expect that your transductants will have the same phenotype(s) as the “white” mutant from which the P1 transducing lysate was made. This is because, upon transduction, there is genetic exchange between the “donor” and “recipient” strains—and a resulting change in phenotype. For example, if mutant B1W1 was genotypically araA::lacZ+, kan, you would expect that the transductants would have the following phenotypes: LB G LB Kan G Mac Ara Kan G, white LB Xgal Kan G, white/light blue LB Ara Xgal Kan G, dark blue If observations were inconsistent with their expectations, you should consider the possibility that their Ara- and KanR phenotypes were not linked. 2. Consider wild type λ phage, the modified λ phage that carried the mini TN10 transposon, the P1 phage we used to make lysates and the P1 phage found in the transducing lysates. Address the following: • Is each lytic, lysogenic, both or neither? a) Wildtype λ phage is both lytic and lysogneic b) The modified λ phage is neither lytic nor lysogneic under the conditions used in the lab. c) The P1 phage used to make lysates was lytic. d) P1 phage found in the transducing lysates was a mixed population, so some were like the P1 used to make the lysates and were thus lytic. Others had packaged bacterial DNA and were neither lytic nor lysogneic. Of the phage stocks used in the lab, which contained a homogenous population of phage? The wild type λ phage and the modified λ phage that carried the mini TN10 transposon • • Which of these carry E. coli DNA? The modified λ phage that carried the mini TN10 transposon had part of the lacZ gene and some of the P1 phage found in the transducing lysates will have packaged bacterial DNA. Also: ( *Not required) a tiny % the P1 phage used to infect the mutants will have host DNA) Of the phage stocks used in the lab, which did you use at high MOI? Which did you use at low MOI? Explain why. a) The modified λ phage was used at low MOI because we wanted any cell that received a transposon to receive 1 and only 1 transposon. This creates a population of mutant cells that each likely carry a single insertion mutation. • b) The P1 phage used to make lysates was used at relatively high MOI because each phage was identical and the overall goal for the experiment was to infect all the cells, hope to get the rare phage that packages host DNA and lyse the cells. More of the P1 phage does not interfere with this goal. c) The P1 phage found in the transducing lysates was used at a very low MOI. It consisted of a mixed population where the vast majority of the phage were like the P1 used to make the lysates and were thus lytic. Only a very small percent of the phage in this population had packaged bacterial DNA and only a few of those carry the transposon. We are selecting for the rare recipient cell that was infected with a phage carrying the transposon. If a second phage were to infect this cell, greater than 99% of the time it would be lytic phage and thus the rare tranductant that we are hoping to find would be killed. 3. During the module, your experiments relied upon random insertion of DNA into the bacterial genome and non-random insertion of DNA into the bacterial genome. • On which days did each occur? On day 1 our experiment relied upon random insertion of DNA. On day 4 our experiment relied upon non-random insertion of DNA. • What was the goal of each? On day 1 our experiment relied upon random insertion of DNA. The goal was to make a population of cells that each had a different transposon insertion mutation. On day 4, the goal was to move the gene carrying the insertion mutation into a new bacterial strain. How was the random insertion of DNA into the bacterial genome accomplished? Name one thing that could have prevented this from occurring. We used a modified λ phage that carried the mini-TN10 transposon to deliver the DNA to the bacterial cell. This phage was no longer lytic or lysogenic and the INT sites of the phage DNA were removed to prevent specific insertions. The gene encoding transposase was carried on a plasmid in the starting strain and expression of enzyme transposase was induced to allow for transposition of the mini-TN10 from the phage DNA into the host DNA. • Any change that prevents transposase from being expressed, any change that interferes with phage adsorption, any change that allowed the λ phage to form a lysogene or lyse the cells could have prevented random insertion from occurring. How was the non-random insertion of DNA into the bacterial genome accomplished? Name one thing that could have prevented this from occurring. The P1 phage used to make transducing lysates. The rare phage in this lysate will carry the gene that is disrupted by the transposon. This phage will deliver this DNA into the recipient cell. The DNA flanking the transposon is identical to DNA in the recipient cell’s genome and this allows homolgous recombination to occur. • No flanking DNA that is holomolgous, Poor lysis during the preparation of the transducing lysates, too high a MOI when using the transducing lysates, other answers acceptable.